Ribociclib – a drug already used to treat breast cancer – may help slow the growth of diffuse hemispheric glioma (DHG), new research has found.
Help us reach the finishing line. Join us in the 'Marathon of Hope'. After the successful return of the Terry Fox Run to London last year we’re so excited to run together again. Help to continue Terry ...
Yvonne Diaz, 55, was diagnosed with stage 4 ALK-positive lung cancer in August 2021. She works in Communications and lives in Holland Park, London with her husband and twin sons, aged 17.
Yvonne Diaz, 55, was diagnosed with stage 4 ALK-positive lung cancer in August 2021. She works in Communications and lives in Holland Park, London with her husband and twin sons, aged 17. Posted on 26 ...
Professor Clare Isacke aims to identify the processes by which tumour cells recruit non-cancerous cells during metastasis. She has held several senior positions at the ICR, including acting as Interim ...
The National Institute for Health and Care Research (NIHR) Biomedical Research Centre (BRC) at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research is the only BRC focused ...
At the ICR, we apply our knowledge of cancer genetics and tumour biology to the discovery of new cancer treatments. We have uncovered more cancer predisposition genes than any other organisation, and ...
Professor Richard Houlston is Head of the Division of Genetics and Epidemiology. His research focuses on the identification and characterisation of genetic susceptibility to cancer. Group: Myeloma ...
A new genetically engineered virus has delivered a one-two punch against advanced cancers in initial findings from a phase I trial. Researchers found that RP2 – a modified version of the herpes ...
The Centre for Cancer Drug Discovery (CCDD) at The Institute of Cancer Research, London, is the largest academic cancer drug discovery and development group worldwide. Its research teams cover every ...
Henry French gives an update on the latest in the story of capivasertib, an exciting cancer drug. The latest major breakthrough in cancer is a drug called capivasertib, which has shown ‘remarkable’ ...
What is the study about? TORPEdO is investigating whether a new type of radiotherapy called proton beam therapy can lessen side effects of throat cancer treatment. Throat cancer is normally treated ...